Management of pharmacovigilance during the COVID‐19 pandemic crisis by the safety department of an academic sponsor: Lessons learnt and challenges from the EU DisCoVeRy clinical trial.
Saved in:
| Title: | Management of pharmacovigilance during the COVID‐19 pandemic crisis by the safety department of an academic sponsor: Lessons learnt and challenges from the EU DisCoVeRy clinical trial. |
|---|---|
| Authors: | Mercier, Noémie1,2 (AUTHOR), Belhadi, Drifa3 (AUTHOR), DeChanet, Aline4 (AUTHOR), Delmas, Christelle5 (AUTHOR), Saillard, Juliette1 (AUTHOR), Dumousseaux, Marina5 (AUTHOR), Le Mestre, Soizic1 (AUTHOR), Fougerou‐Leurent, Claire4 (AUTHOR), Ferrane, Assia5 (AUTHOR), Burdet, Charles3,6,7 (AUTHOR), Espérou, Hélène2 (AUTHOR), Ader, Florence8,9 (AUTHOR), Hites, Maya10 (AUTHOR), Peiffer‐Smadja, Nathan7,11 (AUTHOR), Poissy, Julien12 (AUTHOR), Andrejak, Claire13 (AUTHOR), Paiva, José Artur14 (AUTHOR), Tacconelli, Evelina15 (AUTHOR), Staub, Thérèse16 (AUTHOR), Greil, Richard17 (AUTHOR) |
| Source: | Pharmacology Research & Perspectives. Jun2023, Vol. 11 Issue 3, p1-9. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20521707 |
|---|---|
| DOI: | 10.1002/prp2.1072 |